Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hollis Lin"'
Autor:
Madeline Merkel, David Danese, Chongshu Chen, Jessie Wang, Aozhou Wu, Hongbo Yang, Hollis Lin
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d3b3bd6345cb704727faba74a23c94c
https://doi.org/10.1080/14656566.2023.2215925
https://doi.org/10.1080/14656566.2023.2215925
Autor:
Céline Labeyrie, Sakshi Sethi, Lyuba Popadic, Hongbo Yang, Hollis Lin, Anne-Félice Lainé, David Adams
Publikováno v:
Revue Neurologique. 179:S100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53968e663ec1db46a2ccf474f0bc7453
https://doi.org/10.1016/j.neurol.2023.01.560
https://doi.org/10.1016/j.neurol.2023.01.560
Publikováno v:
Expert Opinion on Pharmacotherapy. 22:121-129
Patisiran and inotersen are two therapies approved for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis with polyneuropathy, a rapidly progressive disease with a substantial clinical burden. This analysis indirectly compares the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910648a41c72dbbeb95fc8c134a0d633
https://doi.org/10.1080/14656566.2020.1811850
https://doi.org/10.1080/14656566.2020.1811850
Autor:
Sonalee Agarwal, William Irish, Saša A. Živković, Danielle Brandman, Jared Gollob, Larry Gache, Hollis Lin, Anastasia McManus
Publikováno v:
Progress in Transplantation. 29:213-219
Introduction: Orthotopic liver transplantation has been used as a treatment for hereditary transthyretin-mediated (hATTR) amyloidosis, a rare, progressive, and multisystem disease. Research Question: The objective is to evaluate survival outcomes pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba9f69d7bbbc5e8ca9bda2ef69e54eb
https://doi.org/10.1177/1526924819853832
https://doi.org/10.1177/1526924819853832
Publikováno v:
Neurodegenerative disease management. 10(5)
Aim: Examine safety and pharmacodynamics of patisiran alone or with concomitant transthyretin stabilizers from the Phase II open-label extension study and safety and efficacy of patisiran in patients with prior transthyretin stabilizer use from the P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52773a5602b976af3b10efc7ec1c67b
https://pubmed.ncbi.nlm.nih.gov/32519928
https://pubmed.ncbi.nlm.nih.gov/32519928
Autor:
John L. Berk, Hollis Lin, Senda Ajroud-Driss, Madeline Merkel, David H. Adams, Taro Yamashita, Alejandra González-Duarte, Ivailo Tournev, Amanda C. Peltier, Ole B. Suhr, Cecilia Hale
Publikováno v:
Heart & Lung. 50:566
Background Hereditary transthyretin-mediated (hATTR) amyloidosis, a rare, multi-systemic, life-threatening disease, causes neurologic and cardiac dysfunction, leading to impaired functional status and declining ability to perform activities of daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd6fcb77d7b87b5e8c013bbbca0d67e1
https://doi.org/10.1016/j.hrtlng.2021.03.066
https://doi.org/10.1016/j.hrtlng.2021.03.066
Autor:
Hollis Lin, Marissa Blieden Betts, Kyle Fahrbach, Michael Polydefkis, Madhura Chitnis, Sonalee Agarwal
Publikováno v:
Expert opinion on pharmacotherapy. 20(12)
We thank the authors of the recent letter to the editor [1] for their thoughtful review of our article, ‘An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatmen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98baa083ca9019071eb24b26b8bf13ba
https://pubmed.ncbi.nlm.nih.gov/31124724
https://pubmed.ncbi.nlm.nih.gov/31124724
Autor:
Alejandra González-Duarte, Yue Wang, Márcia Waddington-Cruz, Madeline Merkel, Mitsuharu Ueda, Hollis Lin, Laura Obici
Publikováno v:
American Journal of Gastroenterology. 115:S1657-S1657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c37402c58b8bc66154b08d37f4cab22f
https://doi.org/10.14309/01.ajg.0000714668.19384.55
https://doi.org/10.14309/01.ajg.0000714668.19384.55
Autor:
Martha Grogan, John L. Berk, Ole B. Suhr, Verena Karsten, Anastasia McManus, John Vest, Christine Powell, Madeline Merkel, Daniel P. Judge, Arnt V. Kristen, Philip N. Hawkins, Hollis Lin
Publikováno v:
Journal of Cardiac Failure. 25:S9-S10
Identifying Mixed Phenotype : Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0531351c68726d38f1d011f88bdaeb96
https://doi.org/10.1016/j.cardfail.2019.07.031
https://doi.org/10.1016/j.cardfail.2019.07.031
Autor:
Hollis Lin, Madeline Merkel, Daniel P. Judge, Yue Wang, Angela Dispenzieri, Alejandra González-Duarte, Michael Polydefkis
Publikováno v:
Journal of Cardiac Failure. 25:S78
Hereditary transthyretin-mediated (hATTR) amyloidosis is a rapidly progressive, multisystem disease which can impact numerous organs, including peripheral and autonomic nerves and heart. Orthostatic intolerance (OI), caused by amyloid deposition in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8476f5dccfbf2f08a04293cb41362de
https://doi.org/10.1016/j.cardfail.2019.07.222
https://doi.org/10.1016/j.cardfail.2019.07.222